GenericCancer Treatment drug in the US after receiving approval from the US FDA. IREDA The company board approved raising Rs 4,500 crore by issuing new shares. HUDCO Received RBI certification […]
Key Updates on Lupin, IREDA, HUDCO, Zomato, NBCC, and Ola ElectricCompanyDetailsLupin Launched a
GenericCancer Treatment drug in the US after receiving approval from the US FDA. IREDA The company board approved raising Rs 4,500 crore by issuing new shares. HUDCO Received RBI certification […]
Key Updates on Lupin, IREDA, HUDCO, Zomato, NBCC, and Ola ElectricCompanyDetailsLupin Launched a
GenericCancer Treatment drug in the US after receiving approval from the US FDA. IREDA The company board approved raising Rs 4,500 crore by issuing new shares. HUDCO Received RBI certification […]
Key Updates on Lupin, IREDA, HUDCO, Zomato, NBCC, and Ola ElectricCompanyDetailsLupin Launched a
GenericCancer Treatment drug in the US after receiving approval from the US FDA. IREDA The company board approved raising Rs 4,500 crore by issuing new shares. HUDCO Received RBI certification […]
Key Updates on Lupin, IREDA, HUDCO, Zomato, NBCC, and Ola ElectricCompanyDetailsLupin Launched a
GenericCancer Treatment drug in the US after receiving approval from the US FDA. IREDA The company board approved raising Rs 4,500 crore by issuing new shares. HUDCO Received RBI certification […]
Key Updates on Lupin, IREDA, HUDCO, Zomato, NBCC, and Ola ElectricCompanyDetailsLupin Launched a
GenericCancer Treatment drug in the US after receiving approval from the US FDA. IREDA The company board approved raising Rs 4,500 crore by issuing new shares. HUDCO Received RBI certification […]
Key Updates on Lupin, IREDA, HUDCO, Zomato, NBCC, and Ola ElectricCompanyDetailsLupin Launched a
GenericCancer Treatment drug in the US after receiving approval from the US FDA. IREDA The company board approved raising Rs 4,500 crore by issuing new shares. HUDCO Received RBI certification […]
UBS Upgrades Voltas to “Buy”: Predicts Market Profit Boost from Voltbek JV
UBS has recently upgraded Voltas from a neutral to a buy rating, signaling strong confidence in the company’s future performance, particularly in the room air conditioner segment. This positive outlook […]